Ascentage Pharma Group International (AAPG) Equity Ratio (2023 - 2025)

Ascentage Pharma Group International (AAPG) has disclosed Equity Ratio for 3 consecutive years, with 0.34 as the latest value for Q4 2025.

  • For Q4 2025, Equity Ratio rose 233.54% year-over-year to 0.34; the TTM value through Dec 2025 reached 0.15, changed N/A, while the annual FY2025 figure was 0.34, 424568.14% up from the prior year.
  • Equity Ratio hit 0.34 in Q4 2025 for Ascentage Pharma Group International, up from 0.1 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.34 in Q4 2025 and bottomed at 0.03 in Q4 2023.
  • Average Equity Ratio over 3 years is 0.16, with a median of 0.1 recorded in 2024.
  • Year-over-year, Equity Ratio skyrocketed 257.27% in 2024 and then skyrocketed 233.54% in 2025.
  • Ascentage Pharma Group International's Equity Ratio stood at 0.03 in 2023, then surged by 257.27% to 0.1 in 2024, then surged by 233.54% to 0.34 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.34, 0.1, and 0.03 for Q4 2025, Q4 2024, and Q4 2023 respectively.